BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22971066)

  • 1. Current dilemmas in antimicrobial therapy in cystic fibrosis.
    Jain K; Smyth AR
    Expert Rev Respir Med; 2012 Aug; 6(4):407-22. PubMed ID: 22971066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections.
    Chmiel JF; Aksamit TR; Chotirmall SH; Dasenbrook EC; Elborn JS; LiPuma JJ; Ranganathan SC; Waters VJ; Ratjen FA
    Ann Am Thorac Soc; 2014 Sep; 11(7):1120-9. PubMed ID: 25102221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis.
    Murray TS; Stanley G; Koff JL
    Infect Dis Clin North Am; 2024 Mar; 38(1):149-162. PubMed ID: 38280761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobials in cystic fibrosis: emergence of resistance and implications for treatment.
    Zabner R; Quinn JP
    Semin Respir Infect; 1992 Sep; 7(3):210-7. PubMed ID: 1475544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis.
    Conway SP; Brownlee KG; Denton M; Peckham DG
    Am J Respir Med; 2003; 2(4):321-32. PubMed ID: 14719998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic Fibrosis.
    Gilligan PH; Downey DG; Elborn JS; Flume PA; Funk S; Gilpin D; Kidd TJ; McCaughan J; Millar BC; Murphy PG; Rendall JC; Tunney MM; Moore JE
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29875191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009528. PubMed ID: 28981972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2015 Mar; (3):CD009528. PubMed ID: 25741986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Smith S; Waters V; Jahnke N; Ratjen F
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD009528. PubMed ID: 32520436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotic therapy of cystic fibrosis in children].
    Kapranov NI; Shabalova LA; Kashirskaia NIu; SimonovaO OI; Voronkova AIu; Osipova IA; Semykin SIu; Polikarpova SV; Postnikov SS
    Antibiot Khimioter; 2001; 46(2):26-32. PubMed ID: 11544748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibiotic treatment of lung disease in cystic fibrosis].
    Biasini GC; Pistocchi E; Miano A
    Pediatr Med Chir; 1983; 5(4):157-60. PubMed ID: 6647075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New antimicrobial strategies in cystic fibrosis.
    van Westreenen M; Tiddens HA
    Paediatr Drugs; 2010 Dec; 12(6):343-52. PubMed ID: 21028914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis.
    Murray TS; Stanley G; Koff JL
    Clin Chest Med; 2022 Dec; 43(4):667-676. PubMed ID: 36344073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection.
    Govan JR; Brown AR; Jones AM
    Future Microbiol; 2007 Apr; 2(2):153-64. PubMed ID: 17661652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus.
    Döring G; Conway SP; Heijerman HG; Hodson ME; Høiby N; Smyth A; Touw DJ
    Eur Respir J; 2000 Oct; 16(4):749-67. PubMed ID: 11106223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung transplantation in cystic fibrosis patients with difficult to treat lung infections.
    Dupont L
    Curr Opin Pulm Med; 2017 Nov; 23(6):574-579. PubMed ID: 28858970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Greally P; Whitaker P; Peckham D
    Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatment.
    Fernández-Barat L; Ciofu O; Kragh KN; Pressler T; Johansen U; Motos A; Torres A; Hoiby N
    J Cyst Fibros; 2017 Mar; 16(2):222-229. PubMed ID: 27651273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.